AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32701012 — intervention group
Group type: EXPERIMENTAL
Intervention: OBG 4 times daily for 14 days (Group 2)
Number of subjects: 45
Study 32701012 — intervention group
Group type: COMPARATOR
Intervention: BCL and artificial tears (Control)
Number of subjects: 45
Study 32701012 — intervention group
Group type: EXPERIMENTAL
Intervention: OBG (Groups 1 and 2)
Number of subjects: 45
Study 33892614 — intervention group
Group type: EXPERIMENTAL
Intervention: Early pushing (allowed to push within one hour after full cervical dilatation)
Number of subjects: 184
Study 33892614 — intervention group
Group type: COMPARATOR
Intervention: Delayed pushing (not allowed to push for maximum of three hours)
Number of subjects: 184
Study 33892614 — intervention group
Group type: COMPARATOR
Intervention: Delayed pushing
Number of subjects: 184
Study 33892614 — intervention group
Group type: EXPERIMENTAL
Intervention: Early pushing
Number of subjects: 184
Study 34814921 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous concentrated growth factor (CGF) after PAOO
Number of subjects: 44
Study 34814921 — intervention group
Group type: COMPARATOR
Intervention: Collagen membrane after PAOO
Number of subjects: 44
Study 35257461 — intervention group
Group type: EXPERIMENTAL
Intervention: iGlarLixi (insulin glargine 100 U/ml + lixisenatide)
Number of subjects: 351
Study 35257461 — intervention group
Group type: COMPARATOR
Intervention: GLP-1RA
Number of subjects: 351
Study 35218726 — intervention group
Group type: EXPERIMENTAL
Intervention: PCE and CAC
Number of subjects: 574
Study 35218726 — intervention group
Group type: EXPERIMENTAL
Intervention: PCE and PRS
Number of subjects: 574
Study 35461642 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional awareness skills training (once a week for 8 weeks)
Number of subjects: 44
Study 35461642 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 44
Study 34847158 — intervention group
Group type: EXPERIMENTAL
Intervention: Moving Stories serious game
Number of subjects: 982
Study 36268677 — intervention group
Group type: EXPERIMENTAL
Intervention: High intensity exercise in the morning
Number of subjects: 14
Study 36268677 — intervention group
Group type: EXPERIMENTAL
Intervention: High intensity exercise in the afternoon
Number of subjects: 14
Study 36268677 — intervention group
Group type: EXPERIMENTAL
Intervention: Karate specific test (KST)
Number of subjects: 14
Study 94240848 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril (ACE inhibitor)
Number of subjects: 21
Study 94240848 — intervention group
Group type: EXPERIMENTAL
Intervention: Sclerotherapy in combination with enalapril
Number of subjects: 21
Study 36222207 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine (7.5 mg daily) in group 1 (early-onset androgenic alopecia)
Number of subjects: 2
Study 36222207 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine (7.5 mg daily) in group 2 (normal hair growth)
Number of subjects: 2
Study 32240760 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor plus placebo
Number of subjects: 2620
Study 32240760 — intervention group
Group type: COMPARATOR
Intervention: Ticagrelor plus aspirin
Number of subjects: 2620
Study 32240760 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor monotherapy
Number of subjects: 2620
Study 36215807 — intervention group
Group type: EXPERIMENTAL
Intervention: Required regular switching condition
Number of subjects: 0
Study 36215807 — intervention group
Group type: EXPERIMENTAL
Intervention: Free-to-choose condition
Number of subjects: 0
Study 36215807 — intervention group
Group type: COMPARATOR
Intervention: Asked-to-stay condition
Number of subjects: 0
Study 34338111 — intervention group
Group type: COMPARATOR
Intervention: Statin users (n = 621)
Number of subjects: 2614
Study 34338111 — intervention group
Group type: COMPARATOR
Intervention: Hydrophilic statins (n = 37)
Number of subjects: 2614
Study 34338111 — intervention group
Group type: COMPARATOR
Intervention: Lipophilic statins (n = 587)
Number of subjects: 2614
Study 34338111 — intervention group
Group type: COMPARATOR
Intervention: Non-selective beta-blockers (n = 113)
Number of subjects: 2614
Study 34338111 — intervention group
Group type: COMPARATOR
Intervention: Non-selective beta-blockers (n = 40)
Number of subjects: 2614
Study 34338111 — intervention group
Group type: COMPARATOR
Intervention: Selective beta-blockers and metformin
Number of subjects: 2614
Study 32398100 — intervention group
Group type: EXPERIMENTAL
Intervention: TIME trial
Number of subjects: 23
Study 34923679 — intervention group
Group type: EXPERIMENTAL
Intervention: Workshop with the PE teachers
Number of subjects: 1279
Study 34923679 — intervention group
Group type: EXPERIMENTAL
Intervention: Workshop with the PE teachers + Doubling PE classes
Number of subjects: 1279
Study 34923679 — intervention group
Group type: EXPERIMENTAL
Intervention: Doubling physical education (PE) classes
Number of subjects: 1279
Study 34923679 — intervention group
Group type: COMPARATOR
Intervention: Control group (1:40 h of PE/week)
Number of subjects: 1279
Study 32236346 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational plan for self-management
Number of subjects: 20
Study 32236346 — intervention group
Group type: COMPARATOR
Intervention: Conventional educational plan
Number of subjects: 20
Study 33164945 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-hour infusion of levodopa/carbidopa (720/90 mg)
Number of subjects: 38
Study 33164945 — intervention group
Group type: EXPERIMENTAL
Intervention: 14-hour 'waking-day' infusion of levodopa/carbidopa (538/68 mg plus a morning oral dose of 150/15 mg)
Number of subjects: 38
Study 33164945 — intervention group
Group type: COMPARATOR
Intervention: Both groups (24-hour and 14-hour)
Number of subjects: 38
Study 32451212 — intervention group
Group type: EXPERIMENTAL
Intervention: Trivalent live human-lamb reassortant rotavirus vaccine (LLR3)
Number of subjects: 0
Study 32451212 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 36424552 — intervention group
Group type: EXPERIMENTAL
Intervention: Transtheoretical model group
Number of subjects: 194
Study 36424552 — intervention group
Group type: COMPARATOR
Intervention: Non-transtheoretical model group
Number of subjects: 194
Study 33355838 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine PICC access
Number of subjects: 66
Study 33355838 — intervention group
Group type: COMPARATOR
Intervention: Usual IV access
Number of subjects: 66
Study 35151280 — intervention group
Group type: EXPERIMENTAL
Intervention: Mictalase® suppositories (Phenolmicin P3 and Bosexil) administered twice a day for 5 days, then once a day for 10 days
Number of subjects: 111
Study 35151280 — intervention group
Group type: COMPARATOR
Intervention: Control group (no Mictalase®)
Number of subjects: 111
Study 33606302 — intervention group
Group type: EXPERIMENTAL
Intervention: Balance Training followed by Explosive Strength Training (BT-ET)
Number of subjects: 0
Study 33606302 — intervention group
Group type: EXPERIMENTAL
Intervention: Explosive Strength Training followed by Balance Training (ET-BT)
Number of subjects: 0
Study 33606302 — intervention group
Group type: COMPARATOR
Intervention: Both groups (BT-ET and ET-BT)
Number of subjects: 0
Study 32257441 — intervention group
Group type: EXPERIMENTAL
Intervention: Unintended pregnancy prevalence
Number of subjects: 612
Study 32257441 — intervention group
Group type: EXPERIMENTAL
Intervention: Family size ≥ 6
Number of subjects: 612
Study 32257441 — intervention group
Group type: EXPERIMENTAL
Intervention: No communication about family planning with husbands
Number of subjects: 612
Study 32257441 — intervention group
Group type: EXPERIMENTAL
Intervention: Parity ≥ 5
Number of subjects: 612
Study 34267167 — intervention group
Group type: COMPARATOR
Intervention: Auto-pulse mode (group A)
Number of subjects: 99
Study 34267167 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-pulse mode (group B)
Number of subjects: 99
Study 34267167 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 99
Study 33075644 — intervention group
Group type: EXPERIMENTAL
Intervention: iAx (instant assessment and feedback system)
Number of subjects: 87
Study 33075644 — intervention group
Group type: COMPARATOR
Intervention: TAU (treatment as usual)
Number of subjects: 87
Study 33075644 — intervention group
Group type: EXPERIMENTAL
Intervention: Both iAx and TAU
Number of subjects: 87
Study 32709656 — intervention group
Group type: EXPERIMENTAL
Intervention: TAU+ACT
Number of subjects: 225
Study 32709656 — intervention group
Group type: EXPERIMENTAL
Intervention: TAU+BATD
Number of subjects: 225
Study 32709656 — intervention group
Group type: COMPARATOR
Intervention: TAU
Number of subjects: 225
Study 32709656 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiological variables
Number of subjects: 225
Study 32709656 — intervention group
Group type: EXPERIMENTAL
Intervention: Polymorphisms in FKBP5 gene
Number of subjects: 225
Study 35507481 — intervention group
Group type: EXPERIMENTAL
Intervention: ZF2001 vaccine (25-μg doses, 3 doses, 30 days apart)
Number of subjects: 25873
Study 35507481 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25873
Study 35604960 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 10 mg Z-endoxifen
Number of subjects: 90
Study 35604960 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 20 mg Z-endoxifen
Number of subjects: 90
Study 35604960 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 33993571 — intervention group
Group type: EXPERIMENTAL
Intervention: alfentanil 14 mcg kg−1
Number of subjects: 114
Study 33993571 — intervention group
Group type: EXPERIMENTAL
Intervention: rocuronium 0.3 mg kg−1
Number of subjects: 114
Study 33993571 — intervention group
Group type: COMPARATOR
Intervention: propofol 2 mg kg−1
Number of subjects: 114
Study 34655071 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracavernosal injection of autologous mesenchymal stem cells (50-60 ×106 cells)
Number of subjects: 20
Study 34655071 — intervention group
Group type: COMPARATOR
Intervention: Normal saline injection (control)
Number of subjects: 20
Study 34655071 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracavernosal injection of autologous mesenchymal stem cells
Number of subjects: 20
Study 32773165 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparins, hydroxychloroquine, and ritonavir/lopinavir
Number of subjects: 238
Study 32773165 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab
Number of subjects: 238
Study 32773165 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticoids
Number of subjects: 238
Study 35491578 — intervention group
Group type: EXPERIMENTAL
Intervention: Collum Femoris Preserving stem (CFP)
Number of subjects: 71
Study 35491578 — intervention group
Group type: COMPARATOR
Intervention: Corail stem
Number of subjects: 71
Study 33544521 — intervention group
Group type: EXPERIMENTAL
Intervention: Noisy galvanic vestibular stimulation (nGVS)
Number of subjects: 0
Study 33544521 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 33407345 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal manipulative therapy at the most pain-sensitive segment
Number of subjects: 132
Study 33407345 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal manipulative therapy at the stiffest segment
Number of subjects: 132
Study 33407345 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 132
Study 32105621 — intervention group
Group type: EXPERIMENTAL
Intervention: NYDA® (a mixture of two dimeticones with different viscosity)
Number of subjects: 106
Study 32105621 — intervention group
Group type: EXPERIMENTAL
Intervention: Dimeticones (general)
Number of subjects: 106
Study 35179802 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent fasting for 12 weeks
Number of subjects: 0
Study 35179802 — intervention group
Group type: COMPARATOR
Intervention: Usual care (standard care group)
Number of subjects: 0
Study 33761968 — intervention group
Group type: EXPERIMENTAL
Intervention: Pragmatic clinical trials
Number of subjects: 0
Study 33761968 — intervention group
Group type: COMPARATOR
Intervention: Traditional randomized clinical trials
Number of subjects: 0
Study 35925834 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid filler with lidocaine (HARL)
Number of subjects: 148
Study 35925834 — intervention group
Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 148
Study 32379165 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical almond oil (6.5 cc applied daily for 7 days)
Number of subjects: 108
Study 32379165 — intervention group
Group type: COMPARATOR
Intervention: Placebo (liquid paraffin, 6.5 cc applied daily for 7 days)
Number of subjects: 108
Study 32379165 — intervention group
Group type: COMPARATOR
Intervention: Control (standard of care)
Number of subjects: 108
Study 32379165 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical almond oil
Number of subjects: 108
Study 32379165 — intervention group
Group type: COMPARATOR
Intervention: Placebo (liquid paraffin)
Number of subjects: 108
Study 35969578 — intervention group
Group type: EXPERIMENTAL
Intervention: Player-labelling (maturation-ordered shirt numbers)
Number of subjects: 24
Study 35969578 — intervention group
Group type: COMPARATOR
Intervention: Uninformed scouts
Number of subjects: 24
Study 32276866 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood transfusion
Number of subjects: 579
Study 34190995 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen therapy
Number of subjects: 565
Study 34550812 — intervention group
Group type: EXPERIMENTAL
Intervention: AMBU AuraGain
Number of subjects: 120
Study 34550812 — intervention group
Group type: COMPARATOR
Intervention: LMA Supreme
Number of subjects: 120
Study 33596508 — intervention group
Group type: EXPERIMENTAL
Intervention: VLCHF diet
Number of subjects: 24
Study 32319999 — intervention group
Group type: EXPERIMENTAL
Intervention: NT‐proBNP‐guided treatment (goal to suppress NT‐proBNP concentrations to <1000 pg/mL)
Number of subjects: 894
Study 32319999 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 894
Study 32319999 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher doses of β‐blockers
Number of subjects: 894
Study 32319999 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher doses of ACE inhibitors
Number of subjects: 894
Study 32319999 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher doses of ARBs
Number of subjects: 894
Study 32319999 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing doses of mineralocorticoid antagonists
Number of subjects: 894
Study 33228733 — intervention group
Group type: EXPERIMENTAL
Intervention: Early essential newborn care (EENC)
Number of subjects: 1349
Study 35947884 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-label placebo treatment for three weeks
Number of subjects: 89
Study 35947884 — intervention group
Group type: COMPARATOR
Intervention: Control group (no open-label placebo treatment)
Number of subjects: 89
Study 33788987 — intervention group
Group type: COMPARATOR
Intervention: LED-RL irradiation at fluences of 160, 320, or 480 J/cm2, triweekly for 3 weeks
Number of subjects: 0
Study 33788987 — intervention group
Group type: COMPARATOR
Intervention: LED-RL irradiation at certain fluences
Number of subjects: 0
Study 33788987 — intervention group
Group type: COMPARATOR
Intervention: LED-RL phototherapy
Number of subjects: 0
Study 33788987 — intervention group
Group type: COMPARATOR
Intervention: Adverse events from LED-RL treatment
Number of subjects: 0
Study 32718927 — intervention group
Group type: EXPERIMENTAL
Intervention: Breaking up sitting with 3-min bouts of light-intensity walking every 30 mins
Number of subjects: 208
Study 32718927 — intervention group
Group type: COMPARATOR
Intervention: Sitting condition (remaining seated during work shifts)
Number of subjects: 208
Study 32718927 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 hour sleep opportunity
Number of subjects: 208
Study 32718927 — intervention group
Group type: EXPERIMENTAL
Intervention: 9 hour sleep opportunity
Number of subjects: 208
Study 35598501 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 50
Study 35598501 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 50
Study 35598501 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 50
Study 34536355 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe stage 2 hypertension
Number of subjects: 0
Study 34536355 — intervention group
Group type: COMPARATOR
Intervention: All higher blood pressure categories
Number of subjects: 0
Study 34536355 — intervention group
Group type: COMPARATOR
Intervention: All lower blood pressure categories
Number of subjects: 0
Study 34151132 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 months of adjuvant afatinib (30 mg by mouth daily)
Number of subjects: 46
Study 34151132 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 years of adjuvant afatinib (30 mg by mouth daily)
Number of subjects: 46
Study 34151132 — intervention group
Group type: COMPARATOR
Intervention: Comparison of 2 years vs 3 months of adjuvant afatinib
Number of subjects: 46
Study 32540134 — intervention group
Group type: COMPARATOR
Intervention: Older adults during speech production and limb movement tasks
Number of subjects: 0
Study 32540134 — intervention group
Group type: COMPARATOR
Intervention: EEG activities in older adults
Number of subjects: 0
Study 32540134 — intervention group
Group type: EXPERIMENTAL
Intervention: Faster motor reaction times in younger adults
Number of subjects: 0
Study 32540134 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre‐motor components of alpha and beta activities in older adults
Number of subjects: 0
Study 35091162 — intervention group
Group type: EXPERIMENTAL
Intervention: Relative ST events with an optimal cut-off at an increment of 85% from baseline
Number of subjects: 1328
Study 34156697 — intervention group
Group type: EXPERIMENTAL
Intervention: Olfactory rehabilitation plus daily oral supplement with Palmitoylethanolamide (PEA) and Luteolin
Number of subjects: 12
Study 34156697 — intervention group
Group type: COMPARATOR
Intervention: Olfactory rehabilitation alone
Number of subjects: 12
Study 35850742 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily Contact Testing (DCT) using Lateral Flow Test (LFT) and two Polymerase Chain Reaction (PCR) tests for 7 days
Number of subjects: 60
Study 35850742 — intervention group
Group type: COMPARATOR
Intervention: Standard self-isolation with one PCR test for 10 days
Number of subjects: 60
Study 34281401 — intervention group
Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplantation (FMT) for 12 weeks
Number of subjects: 12
Study 34281401 — intervention group
Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplantation (FMT)
Number of subjects: 12
Study 34281401 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 33127945 — intervention group
Group type: EXPERIMENTAL
Intervention: 75/650 mg tramadol with paracetamol every 8 hours
Number of subjects: 117
Study 33127945 — intervention group
Group type: COMPARATOR
Intervention: 37.5/325 mg tramadol with paracetamol every 8 hours
Number of subjects: 117
Study 33127945 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 117
Study 35897488 — intervention group
Group type: EXPERIMENTAL
Intervention: Expert message source
Number of subjects: 302
Study 35897488 — intervention group
Group type: COMPARATOR
Intervention: Peer message source
Number of subjects: 302
Study 34156898 — intervention group
Group type: EXPERIMENTAL
Intervention: Romyelocel-L infusion on d9 with granulocyte colony-stimulating factor (G-CSF) starting daily d14
Number of subjects: 163
Study 34156898 — intervention group
Group type: COMPARATOR
Intervention: G-CSF daily alone on d14 (control)
Number of subjects: 163
Study 32093667 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% povidone iodine
Number of subjects: 23
Study 32093667 — intervention group
Group type: COMPARATOR
Intervention: Control group (3% hydrogen peroxide and tap water)
Number of subjects: 23
Study 34459905 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile app for pediatric drug preparation (n = 74)
Number of subjects: 150
Study 34459905 — intervention group
Group type: COMPARATOR
Intervention: Conventional drug preparation methods (n = 76)
Number of subjects: 150
Study 34459905 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile app
Number of subjects: 150
Study 34978535 — intervention group
Group type: EXPERIMENTAL
Intervention: Foundations app
Number of subjects: 136
Study 32844703 — intervention group
Group type: EXPERIMENTAL
Intervention: SIT (sprint interval training; 6 × 20 sec at 140% Wmax)
Number of subjects: 10
Study 32844703 — intervention group
Group type: EXPERIMENTAL
Intervention: MICT (moderate-intensity continuous training; 45 min at 70% Wmax)
Number of subjects: 10
Study 32844703 — intervention group
Group type: COMPARATOR
Intervention: CON (non-exercise trial)
Number of subjects: 10
Study 33636430 — intervention group
Group type: EXPERIMENTAL
Intervention: Overfed diet (HIGH; n = 8)
Number of subjects: 16
Study 33636430 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON‐ diet meeting nutrient requirement; n = 8)
Number of subjects: 16
Study 33636430 — intervention group
Group type: EXPERIMENTAL
Intervention: Both HIGH and CON groups
Number of subjects: 16
Study 35192655 — intervention group
Group type: EXPERIMENTAL
Intervention: 90-day vaginal ring containing tenofovir for HIV prevention
Number of subjects: 49
Study 34233965 — intervention group
Group type: EXPERIMENTAL
Intervention: Nangibotide (two doses)
Number of subjects: 450
Study 34233965 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 450
Study 34233965 — intervention group
Group type: EXPERIMENTAL
Intervention: Nangibotide
Number of subjects: 450
Study 33512812 — intervention group
Group type: EXPERIMENTAL
Intervention: Cap-assisted endoscopic sclerotherapy (CAES)
Number of subjects: 240
Study 33512812 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic variceal ligation (EVL)
Number of subjects: 240
Study 33512812 — intervention group
Group type: COMPARATOR
Intervention: Both CAES and EVL
Number of subjects: 240
Study 33985681 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor plus aspirin
Number of subjects: 19220
Study 33985681 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus aspirin
Number of subjects: 19220
Study 32585284 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic Plasma Exchange (TPE)
Number of subjects: 31
Study 33300284 — intervention group
Group type: EXPERIMENTAL
Intervention: State gratitude
Number of subjects: 326
Study 33300284 — intervention group
Group type: EXPERIMENTAL
Intervention: Trait gratitude
Number of subjects: 326
Study 34157417 — intervention group
Group type: EXPERIMENTAL
Intervention: Live attenuated varicella vaccine
Number of subjects: 894